Substrate Characterization and Outcomes of Ventricular Tachycardia Ablation in Amyloid Cardiomyopathy: A Multicenter Study.
Paolo CompagnucciAntonio Dello RussoAlessio GasperettiMarco SchiavoneOjasav SehrawatKanae HasegawaSanghamitra MohantyJackson Jeikai LiangSuraj C KapaVincenzo Fazia La FaziaFrank BogunWilliam G StevensonClaudio TondoKonstantinos C SiontisHarikrishna TandriPasquale SantangeliSanghamitra MohantyMichela CasellaPublished in: Circulation. Arrhythmia and electrophysiology (2024)
Catheter ablation can achieve control of recurrent VT/VF in more than half of patients with cardiac amyloidosis, and the reduction in VT/VF burden post-ablation may be relevant for quality of life. Septal substrate and risk of procedure-related complications challenge successful management of patients with cardiac amyloidosis and VT/VF.